Combining systemic chemotherapy with chemoembolization in the treatment of unresectable hepatic metastases from colorectal cancer

International Journal of Colorectal Disease

Volumn 21, Issue 1, 2006, Pages 33-37

  You, Yau Tong ^a   Changchien, Chung Rong ^a   Huang, Jen Seng ^a   Ng, Koon Kwan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chemoembolization; Systemic chemotherapy

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; FLUOROURACIL; FOLINIC ACID; IODINATED POPPYSEED OIL; SALICYLIC ACID DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ANOREXIA; ARTERY CATHETERIZATION; ARTICLE; BOLUS INJECTION; CARCINOMATOSIS; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COLORECTAL CANCER; DERMATITIS; DIARRHEA; DRUG DOSE REGIMEN; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; INFECTION COMPLICATION; INOPERABLE CANCER; LEUKOCYTOSIS; LEUKOPENIA; LIVER FAILURE; LIVER METASTASIS; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 29244454012     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-005-0782-x     Document Type: Article

References (25)

1. Kemeny N, Daly J, Reichman B et al (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial. Ann Intern Med 107:459-465 1:STN:280:BiiA38vlsVM%3D
2. Wagner JS, Adson MA, Van Hearden JA et al (1984) The natural history of hepatic metastases from colorectal cancer: A comparison with resective treatment. Ann Surg 5:502-508
3. Kemeny N, Cohen A, Bertino JR (1989) Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma. Cancer 65:2446-2450
4. Machover D (1997) A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer 80:1179-1187
5. Kemeny N, Niedzwiecki D, Shurgot B et al (1989) Prognostic variables in patients with hepatic metastases from colorectal cancer: Importance of medical assessment of liver involvement. Cancer 63:742-747
6. Sanz-Altamira PM, Spence LD, Huberman MS et al (1997) Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: A phase II trial. Dis Colon Rectum 40:770-775 1:STN:280:ByiA28vptVU%3D
7. Hunt TM, Flowerdew ADS, Birch ST et al (1990) Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 77:779-782 1:STN:280:By%2BA2crhsl0%3D
8. Erlichman C, Fine S, Wong A et al (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6:469-475 1:STN:280:BieC2s7mt1E%3D
9. Poon MA, O'connell MJ, Wieand HS et al (1991) Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 9:1967-1972 1:STN:280:By2D2cvntFU%3D
10. Gramont AD, Bosset JF, Milan C et al (1997) Randomized trail comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study. J Clin Oncol 15:808-815 9053508
11. Buroker TR, O'Connell MJ, Wieand HS et al (1994) Randomized comparison of two schedules of fluoreouracil and leucovorin in the treatment of advanced colorectal cancer. J Clin Oncol 12:14-20 1:STN:280:ByuD1MngsV0%3D
12. Stagg RJ, Lewis BJ, Friedman MA et al (1984) Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med 100:736-743 1:STN:280:BiuC2snovV0%3D
13. Jager E, Heike M, Bernhard H et al (1996) Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: Results of a randomized multicenter trial. J Clin Oncol 14:2274-2279 1:STN:280:BymA38nkt1I%3D
14. Lang EK, Brown CL (1993) Colorectal metastases to the liver: Selective chemoembolization. Radiology 189:417-422 1:STN:280:ByuD383ps1U%3D
15. Martinelli DJ, Wadler S, Bakal CW et al (1994) Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma. Cancer 74:1706-1712
16. Becouarn YH, Brunet RC, Rouhier MLP et al (1995) High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer. Cancer 76:1126-1131
17. Ychou M, Raoul JL, Desseigne F et al (2002) High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer. Cancer Chemother Pharmacol 50:383-391 10.1007/ s00280-002-0506-7
18. Rosati G, Rossi A, Reggiardo G et al (2002) A phase II study of irinotecan alternated with a weekly schedule of high dose leucovorin and 48-hour 5- fluorouracil infusion in patients with metastatic colorectal cancer. Oncology 62:209-215 10.1159/000059567
19. Saltz LB, Cox JV, Blanke C et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905-914 10.1056/NEJM200009283431302
20. Cunningham D, Pyrhonen S, James RD et al (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413-1418 10.1016/S0140-6736(98)02309-5
21. Rougier P, Van Cutsem E, Bajetta E et al (1998) Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet 352:1407-1412 10.1016/S0140-6736(98)03085-2
22. Doulliard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial. Lancet 355:1041-1047 10.1016/S0140-6736(00)02034-1
23. Moehler M, Hoffmann T, Hildner K et al (2003) Weekly oxaliplatin, high-dose folinic acid and 24 h 5-fluorouracil (FUFOX) as salvage therapy in metastatic colorectal cancer patients pretreated with irinotecan and folinic acid/5-fluorouracil regimens. Z Gastroenterol 40:957-964 10.1055/s-2002-36156
24. Recchia F, Rea S, Nuzzo A et al (2004) Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer. Anticancer Res 24:1935-1940
25. Levi F, Zidani R, Misset JL et al (1997) International Organization for Cancer Chronotherapy: Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350:681-686 10.1016/S0140-6736(97)03358-8